GlassScriptPhysician profile
Timothy Reis
NPI 1639330236
$10,149.49
in general payments reported to CMS, 2019-2025
38 companies · $1,401 in 2025
The $1,401 reported for 2025 was more than what 79% of Pain Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,199 · 2020: $619 · 2021: $1,066 · 2022: $1,629 · 2023: $2,284 · 2024: $951 · 2025: $1,401.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,794 · Travel and Lodging: $843.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,793.70 |
| Travel and Lodging | $842.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,982.82 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Vectris Surescan |
| Collegium Pharmaceutical, INC. | $1,045.88 | 2019-2025 | Xtampza, Belbuca |
| Medtronic USA, INC. | $799.80 | 2019-2020 | |
| Boston Scientific Corporation | $437.13 | 2022-2025 | General - Therapies, Wavewriter Alpha Prime 16 |
| Scilex Pharmaceuticals INC. | $430.96 | 2019-2024 | Ztlido |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $423.28 | 2019-2025 | Relistor |
| Arbor Pharmaceuticals, INC. | $256.56 | 2019-2022 | |
| Teva Pharmaceuticals USA, INC. | $245.04 | 2019-2022 | |
| Daiichi Sankyo INC. | $241.37 | 2019 | |
| Saluda Medical Americas, INC. | $240.99 | 2024-2025 | Evoke |
| Si-Bone, INC. | $216.08 | 2019-2025 | |
| Bioventus LLC | $177.16 | 2019 | |
| Lilly USA, LLC | $163.95 | 2019-2025 | Zepbound |
| Assertio Therapeutics, INC. | $155.50 | 2019-2020 | |
| Vertex Pharmaceuticals Incorporated | $150.83 | 2024-2025 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $130.40 | 2021 | |
| Grt US Holding, INC. | $99.09 | 2022 | |
| Spr Therapeutics, INC | $95.73 | 2022-2025 | Sprint Pns System |
| Biodelivery Sciences International, INC. | $83.09 | 2020-2021 | |
| Sentynl Therapeutics, INC. | $71.05 | 2019 | |
| Almatica Pharma LLC | $70.10 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $69.78 | 2022 | |
| Redhill Biopharma INC. | $64.97 | 2020-2021 | |
| Abbott Laboratories | $62.71 | 2020-2024 | Eterna |
| Nalu Medical, INC. | $57.80 | 2021-2025 | Nalu Neurostimulation System |
| Fidia Pharma USA INC. | $56.10 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $43.07 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $41.95 | 2021 | |
| Virtus Pharmaceuticals LLC | $37.92 | 2024 | Levorphanol Tartrate |
| Pfizer INC. | $36.98 | 2019-2021 | |
| Forte Bio-Pharma LLC | $32.16 | 2019 | |
| Shionogi INC | $28.26 | 2019 | |
| Electronic Waveform Lab, INC. | $22.56 | 2020 | |
| Abbvie INC. | $20.03 | 2019 | |
| Mdd US Operations, LLC | $17.59 | 2019 | |
| Amneal Pharmaceuticals LLC | $16.83 | 2023 | Lyvispah |
| Baudax Bio INC. | $12.48 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $11.49 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Reis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.